triiodothyronine has been researched along with sertraline in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nemeroff, CB | 1 |
| Jakovljević, M; Korsić, M; Mihaljević-Peles, A; Mück-Seler, D; Pivac, N; Sagud, M | 1 |
| Alajbegovic, L; Baghai, TC; Eser, D; Möller, HJ; Rupprecht, R; Schaaf, L; Schüle, C; Schwarz, M; Zwanzger, P | 1 |
| Apter, JT; Cohen, R; Cooper-Kazaz, R; Drori, T; Glaser, B; Grupper, D; Karagichev, L; Lerer, B; Muhammed-Moussa, S; Newman, ME; Sackeim, HA | 1 |
| Alkelai, A; Cooper-Kazaz, R; Glaser, B; Lerer, B; Medici, M; Peeters, RP; van der Deure, WM; Visser, TJ | 1 |
| Bahls, SC; Boeving, A; de Carvalho, GA; Graf, H | 1 |
| DeFife, JA; Dunlop, BW; Garlow, SJ; Lilienfeld, SO; Marx, L; Nemeroff, CB | 1 |
| Dunlop, BW; Garlow, SJ; Nemeroff, CB; Ninan, PT | 1 |
1 review(s) available for triiodothyronine and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for triiodothyronine and sertraline
| Article | Year |
|---|---|
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder, Major; Electrochemistry; Female; Humans; Immunoassay; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Sertraline; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Triiodothyronine | 2005 |
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyrotropin; Treatment Outcome; Triiodothyronine | 2007 |
Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
Topics: Adult; Aged; Autoantibodies; Depressive Disorder, Major; Fluoxetine; Humans; Hypothyroidism; Iodide Peroxidase; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2009 |
The effects of sertraline on psychopathic traits.
Topics: Adult; Antidepressive Agents; Antisocial Personality Disorder; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Hormones; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Triiodothyronine | 2011 |
The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Treatment Outcome; Triiodothyronine; Young Adult | 2012 |
8 other study(ies) available for triiodothyronine and sertraline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Progress in the battle with the black dog: advances in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Comorbidity; Depression, Postpartum; Depressive Disorder; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Male; Milk, Human; Piperazines; Purines; Sertraline; Sildenafil Citrate; Sulfones; Treatment Outcome; Triiodothyronine | 2001 |
Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients.
Topics: Antidepressive Agents; Case-Control Studies; Depressive Disorder; Female; Humans; Hydrocortisone; Middle Aged; Prolactin; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2002 |
Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine.
Topics: Antidepressive Agents; Depressive Disorder; DNA; Drug Therapy, Combination; Genotype; Humans; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Sertraline; Thyroid Function Tests; Thyrotropin; Triiodothyronine | 2009 |